Full Text View
Tabular View
No Study Results Posted
Related Studies
Sertraline for Preventing Post-Stroke Depression and Improving Rehabilitation Outcomes
This study has been terminated.
( Recruitment goals could not be met. )
Study NCT00177424   Information provided by National Institute of Mental Health (NIMH)
First Received: September 12, 2005   Last Updated: February 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebrovascular Accident
Depression
Additional conditions recognized in this trial
Cerebral Infarction
Depressive Disorder
Stroke
More general conditions related to this trial
Behavioral Symptoms
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Mental Disorders
Mood Disorders
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
sertraline
Placebo
More general drug interventions related to this trial
Antidepressive Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services